https://thelifesciencefeed.com/rare-diseases/pompe-disease/innovation/pompe-disease-why-next-gen-erts-demand-a-new-treatment-calculus The Life Science Feed en 2026-10-28T00:00:00Z Pompe disease: Why next-gen ERTs demand a new treatment calculus https://thelifesciencefeed.com/cardiology/pericarditis/insights/recurrent-pericarditis-why-il-1-blockade-is-changing-the-game The Life Science Feed en 2026-10-28T00:00:00Z Recurrent pericarditis: Why IL-1 blockade is changing the game https://thelifesciencefeed.com/rare-diseases/pompe-disease/insights/late-onset-pompe-why-lungs-fail-before-limbs The Life Science Feed en 2026-10-28T00:00:00Z Late-onset Pompe: Why lungs fail before limbs https://thelifesciencefeed.com/obstetrics-and-gyn/cervical-cancer/insights/cervical-screening-why-arent-we-catching-everyone The Life Science Feed en 2026-10-27T00:00:00Z Cervical screening: Why aren't we catching everyone? https://thelifesciencefeed.com/healthcare-sys-and-biz/biosimilars/insights/adalimumab-biosimilars-why-arent-we-seeing-the-savings-yet The Life Science Feed en 2026-10-27T00:00:00Z Adalimumab biosimilars: Why aren't we seeing the savings yet? https://thelifesciencefeed.com/cardiology/endocarditis/research/endocarditis-do-your-stable-patients-still-need-weeks-of-ivs The Life Science Feed en 2026-10-27T00:00:00Z Endocarditis: Do your stable patients still need weeks of IVs?